Austin Private Wealth, LLC Eli Lilly & CO Call Options Transaction History

Austin Private Wealth, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $1.45 Billion - $1.82 Billion	-1,999,800 Reduced 99.99%	200 $181,000
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $1.45 Billion - $1.82 Billion	1,999,800 Added 999900.0%	2,000,000 $1.81 Billion
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $5.8 Million - $7.76 Million	-9,800 Reduced 98.0%	200 $155,000
Q4 2023 Jan 18, 2024	BUY	$525.19 - $619.13 $5.2 Million - $6.13 Million	9,900 Added 9900.0%	10,000 $5.83 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $43,470 - $59,929	100 New	100 $53,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Austin Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Austin Private Wealth, LLC with notifications on news.